Free Republic
Browse · Search
News/Activism
Topics · Post Article

To: Military family member
Pfizer’s new inhaled insulin form, Exhubera, failed to sell.

Insulin needles these days are very small and hardly noticeable to seasoned diabetics. Dosage is more acurate with a syringe. There was a worry about long term effects on lung function. Marketing departments need to figure out just because something is new doesn't make it better. They also figured there were a bunch of needle phobic diabetics running around. There aren't.

82 posted on 02/20/2008 7:36:38 AM PST by toast
[ Post Reply | Private Reply | To 5 | View Replies ]


To: toast

The bigger problem was that in very few situations would exhubera actually replace the needles. A vast majority of Diabetics still had to take shots.

The other two problems were: a., the size of the unit which was truly huge and rather frightening looking; and B., the $900 per week cost of usage.


89 posted on 02/20/2008 11:48:50 AM PST by Military family member (GO Colts!!)
[ Post Reply | Private Reply | To 82 | View Replies ]

Free Republic
Browse · Search
News/Activism
Topics · Post Article


FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson